Figure S2 from Phase I–II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAFV600MUT Metastatic Melanoma Patients: Uncovering CHEK2 As a Major Response Mechanism
openalex(2023)
关键词
Melanoma,Metastatic Breast Cancer,Breast Cancer
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要